Kan to Lead Global Healthcare Practice at Cohn & Wolfe
Charting the future of public relations
Holmes Report
CEO

Kan to Lead Global Healthcare Practice at Cohn & Wolfe

Cohn & Wolfe has appointed Mike Kan as global healthcare practice leader. Kan will oversee the development of Cohn & Wolfe's global healthcare offering, which includes more than 300 healthcare communications professionals around the world.

Paul Holmes

LONDON—Cohn & Wolfe has appointed Mike Kan as global healthcare practice leader. Kan will oversee the development of Cohn & Wolfe's global healthcare offering, which includes more than 300 healthcare communications professionals around the world. His responsibilities include cultivating client relationships, providing senior counsel, new business development, generating thought leadership, and developing senior talent.

 

Kan will join the firm March 1, and be based in London. He will report directly to Donna Imperato, CEO of Cohn & Wolfe. He joins Cohn & Wolfe from Edelman, where he was head of healthcare for the EMEA region responsible for network integration, business development and client satisfaction.

 

He assumes the role from Linda Dyson who will lead Cohn & Wolfe's healthcare public affairs offering, one of the agency's major business imperatives for 2010 and beyond. Dyson joined Cohn & Wolfe in August 2009 from Roche where she was director of public affairs.

 

"The healthcare industry is undergoing incredible change because of digital media, efforts at reform, and increasing demand for services. As a result, healthcare companies increasingly require an agency with seamless global capabilities and expertise across the entire communications spectrum," said Donna Imperato. "Mike's experience with regional and global programming, and Linda's focus on public affairs, will ensure that Cohn & Wolfe continues to steer healthcare companies through this challenging environment."

 

Kan has more than 18 years of healthcare communications experience. Before becoming head of EMEA healthcare for Edelman, he was U.K. managing director leading the agency's ethical, consumer health and bioscience business units. Prior to Edelman, he was the U.K. practice head and managing director, health and pharmaceuticals, for Hill & Knowlton. He has also worked at Burson-Marsteller and Shire Health.

 

View Style:

Load 3 More
comments powered by Disqus